Literature DB >> 26368927

Evaluation of the Cytosorb™ Hemoadsorptive Column in a Pig Model of Severe Smoke and Burn Injury.

Katharina Linden1, Vittorio Scaravilli, Stefan F X Kreyer, Slava M Belenkiy, Ian J Stewart, Kevin K Chung, Leopoldo C Cancio, Andriy I Batchinsky.   

Abstract

INTRODUCTION: Host inflammatory response to any form of tissue injury, including burn, trauma, or shock, has been well documented. After significant burns, cytokines can increase substantially within the first 24 h after injury and may contribute to subsequent organ failure. Hemoadsorption by cytokine-adsorbing columns may attenuate this maladaptive response, thereby improving outcomes. The aim of this study was to investigate the feasibility, technical safety, and efficacy of cytokine and myoglobin removal by early use of a cytokine absorbing column (CytoSorb) in a porcine model of smoke inhalation and burn injury.
METHODS: Anesthetized female Yorkshire pigs (n = 15) were injured by wood bark smoke inhalation and a 40% total body surface area deep burn and observed for 72 h or death. The animals were randomized to hemoadsorption treatment (n = 9) or a sham group (n = 6) before injury. A 6-h hemoadsorption or sham session was performed on days one, two, and three. Serum cytokines (IL-1b, IL-6, IL-8, IL-10, TNF-alpha) and myoglobin were measured systemically, locally in bronchoalveolar lavage fluid and also in circulating blood before and after the adsorbing column to evaluate single pass clearance by the device.
RESULTS: Hemoadsorption caused significant removal of IL-1b, IL-6, IL-10, and myoglobin across the device mainly during the first run, ranging from 22% for IL-6 to 29% for IL-1b and 41% removal rates for myoglobin after 15  min of treatment. Systemic cytokine or myoglobin serum concentrations did not change.
CONCLUSIONS: In a porcine model of smoke and burn injury, hemoadsorption using the CytoSorb cartridge did not result in significant systemic or pulmonary reductions in the measured cytokines or myoglobin despite efficient transmembrane reductions. Further investigations are needed to optimize the efficiency of mediator clearance to affect both circulating levels and clinically relevant outcomes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26368927     DOI: 10.1097/SHK.0000000000000439

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  12 in total

1.  [Management of severe sepsis using a Cytokin-adsorber].

Authors:  Khosrow Siamak Houschyar; Susanne Rein; Kristian Weissenberg; Dominik Duscher; Hubertus Maria Philipps; Ina Nietzschmann; Torsten Schulz; Frank Siemers
Journal:  Unfallchirurg       Date:  2018-02       Impact factor: 1.000

2.  Role of Elevated Fibrinogen in Burn-Induced Mitochondrial Dysfunction: Protective Effects of Glycyrrhizin.

Authors:  Ryusuke Ueki; Li Liu; Shizuka Kashiwagi; Masao Kaneki; Mohammed A S Khan; Munetaka Hirose; Ronald G Tompkins; Jeevendra A J Martyn; Shingo Yasuhara
Journal:  Shock       Date:  2016-10       Impact factor: 3.454

Review 3.  Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support.

Authors:  L Christian Napp; Stephan Ziegeler; Detlef Kindgen-Milles
Journal:  Blood Purif       Date:  2019-05-16       Impact factor: 2.614

4.  The prognostic value of the nutritional prognostic index (NPI) and controlling nutritional status (CONUT) scoring systems in non-ST elevated myocardial infarction patients over 65 years of age.

Authors:  Bedrettin Boyraz; Ersin Ibisoglu; Burhan Aslan
Journal:  Aging Clin Exp Res       Date:  2022-01-07       Impact factor: 3.636

5.  High performance of a unique mesoporous polystyrene-based adsorbent for blood purification.

Authors:  Jian Chen; Wenyan Han; Jie Chen; Wenhui Zong; Weichao Wang; Yue Wang; Guanghui Cheng; Chunran Li; Lailiang Ou; Yaoting Yu
Journal:  Regen Biomater       Date:  2016-12-24

6.  Effect of TNF-α Concentration on Selected Clinical Parameters of Swine After Burns.

Authors:  Roman Aleksiewicz; Krzysztof Lutnicki; Marta Likus; Łukasz Gątkiewicz
Journal:  J Vet Res       Date:  2018-12-10       Impact factor: 1.744

7.  Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study.

Authors:  Willem Pieter Brouwer; Servet Duran; Martijn Kuijper; Can Ince
Journal:  Crit Care       Date:  2019-09-18       Impact factor: 9.097

8.  Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective 'Genetic' Matched Analysis.

Authors:  Christopher Rugg; Riko Klose; Rouven Hornung; Nicole Innerhofer; Mirjam Bachler; Stefan Schmid; Dietmar Fries; Mathias Ströhle
Journal:  Biomedicines       Date:  2020-11-26

9.  Technical Note: Novel Use of CytoSorb™ Haemadsorption to Provide Wound Healing Support in Case of Severe Burn Trauma via Reduction of Hyperbilirubinaemia.

Authors:  Katarzyna Rachunek; Maja Krause; Johannes Tobias Thiel; Jonas Kolbenschlag; Adrien Daigeler; Andreas Bury
Journal:  Front Surg       Date:  2021-12-17

10.  Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.

Authors:  Abdulrahman Alharthy; Fahad Faqihi; Ziad A Memish; Abdullah Balhamar; Nasir Nasim; Ahmad Shahzad; Hani Tamim; Saleh A Alqahtani; Peter G Brindley; Dimitrios Karakitsos
Journal:  Artif Organs       Date:  2020-12-26       Impact factor: 2.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.